News

Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...
Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...
Eli Lilly (LLY) reports Q2 earnings on Aug 7, with booming diabetes and weight-loss drug sales driving strong growth.
Eli Lilly offers an annual dividend yield of 0.78%. So, how can investors exploit its dividend yield to pocket a regular $500 ...
Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...
Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second quarter ...
The 2026 Lilly Endowment Community Scholarship application is now available in Brown County through the Brown County ...
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...
Lilly Erickson’s journey in skateboarding started in Hawaii with a Target board covered in hearts—now she’s riding for ...
The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.
The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.
On the one hand, the company is struggling to stay competitive with its chief rival Eli Lilly, and on the other, compounders ...